Respiratory disease trends in the pulmonary complications of HIV infection study cohort

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 1, 1997, Pages 72-80

  Wallace, Jeanne Marie ^e,i   Hansen, Nellie I ^g   LaVange, Lisa ^g   Glassroth, Jeffrey ^b   Browdy, Ben L ^e   Rosen, Mark J ^c   Kvale, Paul A ^f   Mangura, Bonita T ^d   Reichman, Lee B ^d   Hopewell, Philip C ^a   Stansell, John ^a   Turner, Joan ^a   Merrifield, Cynthia ^a   Osmond, Dennis ^a   Mossar, Melinda ^b   Hirschtick, Robert ^b   Meiselman, Lori ^c   Manghisi, Kim K ^c   Schneider, Roslyn F ^c   Barnes, Sandra ^d   Le Maire, Barbara ^e   Richer, Barbara ^e   Clemente, Virgilio ^e   Au, Janet ^e   Coulson, Anne ^e   Sayre, James ^e   Markowitz, Norman ^f   Saravolatz, Louis D ^f   Johnson, Christine ^f   Huitsing, Joanne ^f   Krystotorski, Annmarie ^f   Poole, W Kenneth ^g   Rao, A Vijaya ^g   Clayton, Kim ^g   Jordan, Matt ^g   Thompson, Jim ^g   Myers, David ^g   Katzin, Judith ^g   Fulkerson, William ^g   Lou, Yu ^g   Wilcosky, Tim ^g   Kalica, Anthony R ^h   Wittes, Janet ^h   Follman, Dean ^h   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g RTI INTERNATIONAL   (United States)

^h National Institute of AIDS and Infectious Diseases   (United States)

ⁱ OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CELL COUNT; CHEMOPROPHYLAXIS; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; LUNG INFECTION; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 8044242920     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.1.9001292     Document Type: Article

References (31)

1. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
2. Munoz, A., M. C. Wang, S. Bass, J. M. G. Taylor, L. A. Kingsley, J. S. Chmiel, B. F. Polk, and the Multicenter AIDS Cohort Study Group. 1989. Acquired immunodeficiency syndrome (AIDS) free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am. J. Epidemiol. 130:530-539.
3. Fauci, A. S., S. M. Schnittman, G. Poli, S. Koenig, and G. Pantaleo. 1991. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 114:678-693.
4. Rutherford, G. W., A. R. Lifson, N. A. Hessol, W. W. Darrow, P. M. O'Malley, S. P. Buchbinder, J. L. Barnhart, T. W. Bodecker, L. Cannon, L. S. Doll, S. D. Holmberg, J. S. Harrison, M. F. Rogers, D. Werdegar, and H. W. Jaffe. 1990. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow-up study. B.M.J. 301:1183-1188.
5. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
6. Murray, J. F., C. P. Felton, S. M. Garay, M. S. Gottlieb, P. C. Hopewell, D. E. Stover, and A. S. Tierstien. 1984. Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung and Blood Institute workshop. N. Engl. J. Med. 310: 1682-1688.
7. Murray, J. F., S. M. Garay, P. C. Hopewell, J. Mills, G. L. Snider, and D. E. Stover. 1987. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am. Rev. Respir. Dis. 135: 504-509.
8. Wallace, J. M., A. V. Rao, J. Glassroth, N. I. Hansen, M. J. Rosen, C. Arakaki, P. A. Kvale, L. B. Reichman, P. C. Hopewell, and the Pulmonary Complications of HI V Infection Study Group. 1993. Respiratory illness in persons with human immunodeficiency virus infection Am. Rev. Respir. Dis. 148:523-529.
9. Murray, J. F., and J. Mills. 1990. Pulmonary infectious complications of human immunodeficiency virus infections. Parts 1 and 2. Am. Rev. Respir. Dis. 141:1356-1372, 1582-1598.
10. White, D. A., and R. A. Matthay. 1989. Noninfectious pulmonary complications of infection with the immunodeficiency virus. Am. Rev. Respir. Dis. 140:1623-1633.
11. Pulmonary Complications of HIV Infection Study Group. 1993. The prospective study of pulmonary complications of human immunodeficiency virus infection. J. Clin. Epidemiol. 46:497-507.
12. Centers for Disease Control. 1987. Revision of the CDC Surveillance Case Definition for acquired immunodeficiency syndrome. M. M. W. R. 36(Suppl. 1S):3S-15S.
13. Rothman, K. J. 1986. Modern Epidemiology. Little, Brown and Company, Boston.
14. LaVange, L. M., L. L. Keyes, G. G. Koch, and P. A. Margolis. 1994. Application of sample survey methods for modelling ratios lo incidence densities. Statist. Med. 13:343-355.
15. Liang K. Y., and S. L. Zeger. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73:13-22.
16. Zeger, S. L., and K. Y. Liang. 1986. Longitudinal data analysis of discrete and continuous outcomes. Biometrics 42:121-130.
17. Schneider, M. M. E., A. I. M. Hoepelman, J. K. M. Eeftinck Schattenkerk, T. L. Nielsen, Y. Van der Graaf, J. P. H. J. Frissen, I. M. E. Van der Ende, A. F. P. Kolsters, J. C. C. Borleffs, and the Dutch Aids Treatment Group. 1992. A controlled trial of aerosolized pentamidine or trimethaprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327:1836-1841.
18. Hardy, W. D., J. Feinberg, D. M. Finkelstein, M. E. Power, W. He, C. Kaczka, P. T. Frame, M. Holmes, H. Waskin, R. J. Fass, W. G. Powderly, R. T. Steigbigel, A. Zuger, and R. S. Holzman for the AIDS Clinical Trials Group. 1992. A controlled trial of trimethaprim-sulfmethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N. Engl. J. Med. 327:1842-1848.
19. Masur, H. 1992. Prevention and treatment of pneumocystis pneumonia. N. Engl. J. Med. 327:1853-1860.
20. Munoz, A., L. K. Schrager, H. Bacellar, I. Speizer, S. H. Vermund, R. Detels, A. J. Saah, L. A. Kingsley, D. Seminara, and J. Phair. 1993. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am. J. Epidemiol. 137:423-438.
21. Hoover, D. R., A. J. Saah, H. Bacellar, J. Phair, R. Detels, R. Anderson, and R. A. Kaslow for the Multicenter AIDS Cohort. 1993. Clinical manifestations of AIDS in the area of pneumocystis prophylaxis. N. Engl. J. Med. 329:1922-1926.
22. Hirschtick, R. E., J. Glassroth, M. C. Jordan, T. C. Wilcosky, J. M. Wallace, P. A. Kvale, N. Markowitz, M. J. Rosen, B. T. Mangura, P. C. Hopewell, and the Pulmonary Complications of HIV Infection Study Group. 1995. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N. Engl. J. Med. 333:845-851.
23. Selwyn, P. A., A. R. Feingold, D. Hartel, E. E. Schoenbaum, M. H. Alderman, R. S. Klein, and G. H. Friedland. 1988. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 2:267-272.
24. Masur, H., F. P. Ognibene, R. Yarchoan, J. H. Shelhamer, B. F. Baird, W. Travis, A. E. Suffredini, L. Deyton, J. A. Kovacs, J. Falloon, R. Davey, M. Polis, J. Metcalf, J. Baseler, R. Wesley, Y. J. Gill, A. S. Fauci, and H. C. Lane. 1989. CD4 counts as predictors of opportunistic pneumonia in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 111:223-230.
25. Bozzette, S. A., D. M. Finklestein, S. A. Spector, P. Frame, W. G. Powderly, W. He, L. Phillips, D. Craven, C. Van der Horst, and J. Feinberg for the NIAID AIDS Clinical Trails Group. 1995. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332:693-699.
26. Saah, A. J., D. R. Hoover, Y. Peng, J. P. Phair, B. Visscher, L. A. Kingsley, and L. K. Schrager for the Multicenter AIDS Cohort Study. 1995. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. J.A.M.A. 273:1197-1202.
27. Reider, H. L., G. M. Cauthen, G. P. Kelly, A. B. Black, and D. E. Snider, Jr. 1989. Tuberculosis in the United States. J.A.M.A. 262: 385-389.
28. Brudny, K., and J. Dobkin. 1991. Resurgent tuberculosis in New York. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 144:745-749.
29. Barnes, P. F., and S. A. Barrows. 1993. Tuberculosis in the 1990's. Ann. Intern. Med. 119:400-410.
30. Pape, J. W., S. S. Jean, J. L. Ho, A. Hafner, and W. D. Johnson. 1993. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HlV infection. Lancet 342:268-272.
31. O'Brien, R. J., and J. H. Perriens. 1995. Preventive therapy for tuberculosis in HIV infection: the promise and reality. AIDS 9:665-673.